Washington Wire

The chairman of the Senate Finance Committee doubled down on his commitment to have a pharmacy benefit manager reform bill passed during Congress’ lame duck session later this year.

The Senate Finance Committee hearing Thursday drilled down on the coming battle over whether to renew the tax cuts passed in 2017.

Matthew Tassey has been an advocate for the insurance industry throughout his extensive career.

Voters may be passionate about their favorite candidates, but the winner of the election doesn’t matter to the market.

Abortion, Medicaid, Medicare, the Inflation Reduction Act and LGBTQ+ protections could be impacted.

The Biden administration announced today it has reached agreements for new, lower prices for 10 of Medicare’s most popular and costliest prescribed drugs.

Members of Health Agents for America returned from their 2024 Agent Summit in Washington, where they discussed issues ranging from the practice of “twisting” to the impact of the Inflation Reduction Act on Medicare Part D with their elected representatives in Congress.

Short-term limited duration insurance is the subject of new restrictions by the federal government.

U.S. deficits loom, and while that is a long-term consideration, we do not expect it to discourage insurers from adding to their fixed income exposure in the near-term.

The Court of Appeals for the Fifth Circuit tossed out the Biden administration’s ESG rule in a decision posted this morning.

With Congress focusing on trying to pass 2024-2025 government spending bills, some bipartisan health care reforms will likely be punted to late this year.

The U.S. 5th Circuit Court of Appeals ruled that a Christian-owned business can’t be compelled to cover preventive medications as is required under the Affordable Care Act.

Provisions of the Tax Cuts and Jobs Act of 2017 that impact individual taxpayers will expire at the end of 2025 unless Congress acts.

The Medical Debt Cancellation Act seeks to alleviate financial stress for Americans burdened by health care expenses.

The Connelly decision may generate questions about buy-sell agreements from clients and their tax and legal teams.

Connelly v. U.S. questioned whether the proceeds of a life insurance policy taken out by a closely held company on a shareholder constitutes an asset of the company when calculating the value of the shareholder’s shares for purposes of the federal estate tax.